Namely, smokers with GSTP1-variant genotype were at 2.87-fold higher risk of developing cRCC (OR = 2.87, 95%CI:1.45–5.69, p = 0.002) than smokers carrying GSTP1 wild-type genotype. This evidence concerns the gene GSTP1 and chromophobe renal cell carcinoma.